Literature DB >> 22949073

Increasing prevalence rates of HPV attributable oropharyngeal squamous cell carcinomas in the Netherlands as assessed by a validated test algorithm.

Michelle M Rietbergen1, C René Leemans, Elisabeth Bloemena, Daniëlle A M Heideman, Boudewijn J M Braakhuis, Albertus T Hesselink, Birgit I Witte, Robert J Baatenburg de Jong, Chris J L M Meijer, Peter J F Snijders, Ruud H Brakenhoff.   

Abstract

Human papillomavirus (HPV) infection has been etiologically linked to oropharyngeal squamous cell carcinoma (OPSCC). The prevalence of HPV-positive OPSCC varies between studies, ranging from 20 to 90%. This may be related to the lack of a standardized HPV detection assay as well as to the time period in which HPV prevalence is investigated, as rising incidence rates are reported over the last decades. Here, we validated our previously defined test algorithm for HPV detection in formalin-fixed paraffin-embedded (FFPE) tumor specimen consisting of p16(INK4A) immunostaining followed by high-risk HPV DNA detection by GP5+/6+ PCR on the positive cases (Smeets et al., Int J Cancer 2007;121:2465-72). In addition, we analyzed HPV prevalence rates in OPSCCs in the years 1990-2010. The test algorithm was validated on a consecutive series of 86 OPSCCs collected during 2008-2011, of which both fresh frozen and FFPE samples were available. We performed HPV-E6 RT-PCR on the frozen samples as gold standard and applied the algorithm to the corresponding FFPE samples. The test algorithm showed an accuracy of 98%. Using the validated algorithm, we determined the presence of an oncogenic HPV infection in 240 OPSCCs of patients diagnosed in the years 1990-2010 at our center. A significant increase in the proportion of HPV-positive samples was observed, from 5.1% in 1990 to 29.0% in 2010 (p = 0.001). In conclusion, we confirmed the accuracy of the test algorithm for HPV detection in FFPE tumor specimen and we found a significant increase in the prevalence of HPV in OPSCC over the last two decades at our center.
Copyright © 2012 UICC.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22949073     DOI: 10.1002/ijc.27821

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  65 in total

1.  Quantitative diffusion-weighted MRI parameters and human papillomavirus status in oropharyngeal squamous cell carcinoma.

Authors:  C S Schouten; P de Graaf; E Bloemena; B I Witte; B J M Braakhuis; R H Brakenhoff; C R Leemans; J A Castelijns; R de Bree
Journal:  AJNR Am J Neuroradiol       Date:  2015-02-26       Impact factor: 3.825

Review 2.  Prevalence of Human Papillomavirus in Oropharyngeal Cancer: A Systematic Review.

Authors:  Andrew P Stein; Sandeep Saha; Jennifer L Kraninger; Adam D Swick; Menggang Yu; Paul F Lambert; Randall J Kimple
Journal:  Cancer J       Date:  2015 May-Jun       Impact factor: 3.360

3.  Human papillomavirus DNA detection, p16INK4a, and oral cavity cancer in a U.S. population.

Authors:  Brenda Y Hernandez; Charles F Lynch; Owen T M Chan; Marc T Goodman; Elizabeth R Unger; Martin Steinau; Trevor D Thompson; Maura Gillison; Christopher Lyu; Mona Saraiya
Journal:  Oral Oncol       Date:  2019-03-05       Impact factor: 5.337

4.  Innovations in risk-stratification and treatment of Veterans with oropharynx cancer; roadmap of the 2019 Field Based Meeting.

Authors:  V C Sandulache; Y L Lei; L E Heasley; M Chang; C I Amos; E M Sturgis; E Graboyes; E Y Chiao; N Rogus-Pulia; J Lewis; A Madabhushi; M J Frederick; A Sabichi; M Ittmann; W G Yarbrough; C H Chung; R Ferrarotto; Weiyuan Mai; H D Skinner; U Duvvuri; P Gerngross; A G Sikora
Journal:  Oral Oncol       Date:  2019-10-22       Impact factor: 5.337

5.  Identification of human papillomavirus (HPV) subtype in oral cancer patients through microarray technology.

Authors:  Soung Min Kim; Ik Jae Kwon; Hoon Myoung; Jong Ho Lee; Suk Keun Lee
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-12-09       Impact factor: 2.503

Review 6.  The molecular landscape of head and neck cancer.

Authors:  C René Leemans; Peter J F Snijders; Ruud H Brakenhoff
Journal:  Nat Rev Cancer       Date:  2018-03-02       Impact factor: 60.716

Review 7.  The prevalence of human papillomavirus in squamous cell carcinoma of unknown primary site metastatic to neck lymph nodes: a systematic review.

Authors:  Paolo Boscolo-Rizzo; Lea Schroeder; Salvatore Romeo; Michael Pawlita
Journal:  Clin Exp Metastasis       Date:  2015-09-10       Impact factor: 5.150

Review 8.  Epidemiology of Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma.

Authors:  Maura L Gillison; Anil K Chaturvedi; William F Anderson; Carole Fakhry
Journal:  J Clin Oncol       Date:  2015-09-08       Impact factor: 44.544

9.  MMP-7 expression may influence the rate of distant recurrences and disease-specific survival in HPV-positive oropharyngeal squamous cell carcinoma.

Authors:  Seija I Vento; Lauri Jouhi; Hesham Mohamed; Caj Haglund; Antti A Mäkitie; Timo Atula; Jaana Hagström; Laura K Mäkinen
Journal:  Virchows Arch       Date:  2018-05-02       Impact factor: 4.064

10.  Detection of HPV infection in head and neck squamous cell carcinoma: a practical proposal.

Authors:  Johannes H Dreyer; Franziska Hauck; Michelle Oliveira-Silva; Mario Henrique M Barros; Gerald Niedobitek
Journal:  Virchows Arch       Date:  2013-03-17       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.